(Q73437155)

English

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplan

scientific article published on 01 May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Nancy J. Tarbell

6

object named as

Nancy Tarbell

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Bimalangshu R Dey

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Steven McAfee

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Christine Colby

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Robert Sackstein

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Susan Saidman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

David H Sachs

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Megan Sykes

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Thomas R Spitzer

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

320-329

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

How does bone-marrow transplantation cure leukaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900077-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1083-8791(03)00077-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766882%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73437155&oldid=1871639408"